Autophagy: Cancer therapy's friend or foe?

Future Medicinal Chemistry

Volumn 2, Issue 2, 2010, Pages 285-297

  Grandér, Dan ^a   Panaretakis, Theocharis ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHAGY; CANCER THERAPY; CARCINOGENESIS; CELL DEATH; CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

AUTOPHAGY; CELL DEATH; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; ORGANELLES; SIGNAL TRANSDUCTION;

EID: 77953470459     PISSN: 17568919     EISSN: None     Source Type: Journal    
DOI: 10.4155/fmc.09.155     Document Type: Review

References (99)

1. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 132(1), 27-42 (2008).
2. Eisenberg-Lerner A, Bialik S, Simon HU, Kimchi A. Life and death partners: apoptosis autophagy and the cross-talk between them. Cell Death Differ. 16(7), 966-975 (2009).
3. Eisenberg-Lerner A, Kimchi A. The paradox of autophagy and its implication in cancer etiology and therapy. Apoptosis 14(4), 376-391 (2009).
4. Ravikumar B, Vacher C, Berger Z et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36(6), 585-595 (2004).
5. Virgin HW, Levine B. Autophagy genes in immunity. Nat. Immunol. 10(5), 461-470 (2009).
6. Nakagawa I, Amano A, Mizushima N et al. Autophagy defends cells against invading group A Streptococcus. Science 306(5698), 1037-1040 (2004).
7. Martinez-Vicente M, Sovak G, Cuervo AM. Protein degradation and aging. Exp. Gerontol. 40(8-9), 622-633 (2005).
8. Kondo Y, Kondo S. Autophagy and cancer therapy. Autophagy 2(2), 85-90 (2006).
9. Levine B. Cell biology: autophagy and cancer. Nature 446(7137), 745-747 (2007).
10. Espert L, Denizot M, Grimaldi M et al. Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J. Clin. Invest. 116(8), 2161-2172 (2006).
11. Kunchithapautham K, Rohrer B. Apoptosis and autophagy in photoreceptors exposed to oxidative stress. Autophagy 3(5), 433-441 (2007).
12. Ding WX, Ni HM, Gao W et al. Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival. J. Biol. Chem. 282(7), 4702-4710 (2007).
13. Crighton D, Wilkinson S, O'Prey J et al. DRAM, a p53-induced modulator of Autophagy is critical for apoptosis. Cell 126(1), 121-134 (2006).
14. Levine B, Kroemer G. Autophagy in aging, disease and death: the true identity of a cell death impostor. Cell Death Differ. 16(1), 1-2 (2009).
15. Mathew R, Karp CM, Beaudoin B et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 137(6), 1062-1075 (2009).
16. Cuervo AM. Autophagy: in sickness and in health. Trends Cell Biol. 14(2), 70-77 (2004).
17. Mathew R, Karantza-Wadsworth V, White E. Role of autophagy in cancer. Nat. Rev. Cancer 7(12), 961-967 (2007).
18. Karantza-Wadsworth V, Patel S, Kravchuk O et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev. 21(13), 1621-1635 (2007).
19. Sato K, Tsuchihara K, Fujii S et al. Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res. 67(20), 9677-9684 (2007).
20. Fujii S, Mitsunaga S, Yamazaki M et al. Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. Cancer Sci. 99(9), 1813-1819 (2008).
21. Lu Z, Luo RZ, Lu Y et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J. Clin. Invest. 118(12), 3917-3929 (2008).
22. Amaravadi RK. Autophagy-induced tumor dormancy in ovarian cancer. J. Clin. Invest. 118(12), 3837-3840 (2008).
23. Gingras AC, Raught B, Sonenberg N. Control of translation by the target of rapamycin proteins. Prog. Mol. Subcell. Biol. 27, 143-174 (2001).
24. Scott JW, Oakhill JS, van Denderen BJ. AMPK/SNF1 structure: a menage a trois of energy-sensing. Front. Biosci. 14, 596-610 (2009).
25. Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1(1), 15-25 (2005).
26. Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115(5), 577-590 (2003).
27. Inoki K, Li Y, Xu T, Guan KL. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17(15), 1829-1834 (2003).
28. Carling D. The AMP-activated protein kinase cascade - a unifying system for energy control. Trends Biochem. Sci. 29(1), 18-24 (2004).
29. Shaw RJ, Lamia KA, Vasquez D et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310(5754), 1642-1646 (2005).
30. Shaw RJ, Kosmatka M, Bardeesy N et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl Acad. Sci USA 101(10), 3329-3335 (2004).
31. Liang J, Shao SH, Xu ZX et al. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat. Cell Biol. 9(2), 218-224 (2007).
32. Axe EL, Walker SA, Manifava M et al. Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J. Cell Biol. 182(4), 685-701 (2008).
33. Ichimura Y, Kirisako T, Takao T et al. A ubiquitin-like system mediates protein lipidation. Nature 408(6811), 488-492 (2000).
34. Kabeya Y, Mizushima N, Ueno T et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19(21), 5720-5728 (2000).
35. Kirisako T, Ichimura Y, Okada H et al. The reversible modification regulates the membrane-binding state of Apg8/Aut7 essential for autophagy and the cytoplasm to vacuole targeting pathway. J. Cell Biol. 151(2), 263-276 (2000).
36. Ishihara N, Hamasaki M, Yokota S et al. Autophagosome requires specific early Sec proteins for its formation and NSF/SNARE for vacuolar fusion. Mol. Biol. Cell 12(11), 3690-3702 (2001).
37. Kang MR, Kim MS, Oh JE et al. Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J. Pathol. 217(5), 702-706 (2009).
38. Liang XH, Jackson S, Seaman M et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402(6762), 672-676 (1999).
39. Chen Y, Lu Y, Lu C, Zhang L. Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1a expression. Pathol. Oncol. Res. 15(3), 487-493 (2009).
40. Lee JW, Jeong EG, Lee SH, Yoo NJ. Somatic mutations of BECN1, an autophagy-related gene, in human cancers. APMIS, 115(6), 750-756 (2007).
41. Wei Y, Pattingre S, Sinha S, Bassik M, Levine B. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol. Cell 30(6), 678-688 (2008).
42. Zalckvar E, Berissi H, Mizrachy L et al. DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy. EMBO Rep, 10(3), 285-292 (2009).
43. Yee KS, Wilkinson S, James J, Ryan KM, Vousden KH. PUMA- and Bax-induced autophagy contributes to apoptosis. Cell Death Differ. 16, 1135-1145 (2009).
44. Zhang J, Ney PA. Role of BNIP3 and NIX in cell death, Autophagy, and mitophagy. Cell Death Differ. 16(7), 939-946 (2009).
45. Maiuri MC, Le Toumelin G, Criollo A et al. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J. 26(10), 2527-2539 (2007).
46. Lin J, Zheng Z, Li Y et al. A novel Bcl-XL inhibitor Z36 that induces autophagic cell death in Hela cells. Autophagy 5(3), 314-320 (2009).
47. Liang C, Feng P, Ku B et al. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat. Cell Biol. 8(7), 688-699 (2006).
48. Takahashi Y, Coppola D, Matsushita N et al. Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat. Cell Biol. 9(10), 1142-1151 (2007).
49. Kissil JL, Feinstein E, Cohen O et al. DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene. Oncogene 15(4), 403-407 (1997).
50. Debatin KM. Chronic lymphocytic leukemia: keeping cell death at bay. Cell 129(5), 853-855 (2007).
51. Inoki K, Guan KL. Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment. Hum. Mol. Genet. 18(R1), R94-R100 (2009).
52. Maiuri MC, Malik SA, Morselli E et al. Stimulation of autophagy by the p53 target gene Sestrin2. Cell Cycle 8(10), 1571-1576 (2009).
53. Tasdemir E, Maiuri MC, Galluzzi L et al. Regulation of autophagy by cytoplasmic p53. Nat. Cell Biol. 10(6), 676-687 (2008).
54. Humbey O, Pimkina J, Zilfou JT et al. The ARF tumor suppressor can promote the progression of some tumors. Cancer Res. 68(23), 9608-9613 (2008).
55. Pimkina J, Murphy ME. ARF, autophagy and tumor suppression. Autophagy 5(3), 397-399 (2009).
56. Chu IM, Hengst L, Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat. Rev. Cancer 8(4), 253-267 (2008).
57. Crazzolara R, Bradstock KF, Bendall LJ. RAD001 (Everolimus) induces autophagy in acute lymphoblastic leukemia. Autophagy 5(5), 1297-1309 (2009).
58. Younes A. Therapeutic activity of mTOR inhibitors in mantle cell lymphoma: clues but no clear answers. Autophagy 4(5), 707-709 (2008).
59. Witzig TE, Geyer SM, Ghobrial I et al. Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma. J. Clin. Oncol. 23(23), 5347-5356 (2005).
60. Laane E, Tamm KP, Buentke E et al. Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death Differ. 16(7), 1018-1029 (2009).
61. Swerdlow S, McColl K, Rong Y, Lam M, Gupta A, Distelhorst CW. Apoptosis inhibition by Bcl-2 gives way to autophagy in glucocorticoid-treated lymphocytes. Autophagy 4(5), 612-620 (2008).
62. Yang YP, Liang ZQ, Gao B, Jia YL, Qin ZH. Dynamic effects of autophagy on arsenic trioxide-induced death of human leukemia cell line HL60 cells. Acta Pharmacol Sin. 29(1), 123-134 (2008).
63. Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ. 11(4), 448-457 (2004).
64. Qian W, Liu J, Jin J, Ni W, Xu W. Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1. Leuk. Res. 31(3), 329-339 (2007).
65. Kanzawa T, Zhang L, Xiao L, Germano IM, Kondo Y, Kondo S. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene 24(6), 980-991 (2005).
66. Chen Y, Azad MB, Gibson SB. Superoxide is the major reactive oxygen species regulating autophagy. Cell Death Differ. 16(7), 1040-1052 (2009).
67. Azad MB, Chen Y, Gibson SB. Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment. Antioxid. Redox Signal. (2008).
68. Scherz-Shouval R, Elazar Z. ROS, mitochondria and the regulation of autophagy. Trends Cell Biol. 17(9), 422-427 (2007).
69. Scherz-Shouval R, Shvets E, Elazar Z. Oxidation as a post-translational modification that regulates autophagy. Autophagy 3(4), 371-373 (2007).
70. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J. 26(7), 1749-1760 (2007).
71. Chen Y, McMillan-Ward E, Kong J, Israels SJ, Gibson SB. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ. 15(1), 171-182 (2008).
72. Bursch W, Hochegger K, Torok L, Marian B, Ellinger A, Hermann RS. Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. J. Cell Sci. 113(7), 1189-1198 (2000).
73. Schoenlein PV, Periyasamy-Thandavan S, Samaddar JS, Jackson WH, Barrett JT. Autophagy facilitates the progression of ERa-positive breast cancer cells to antiestrogen resistance. Autophagy 5(3), 400-403 (2009).
74. John S, Nayvelt I, Hsu HC et al. Regulation of estrogenic effects by beclin 1 in breast cancer cells. Cancer Res. 68(19), 7855-7863 (2008).
75. Apel A, Herr I, Schwarz H, Rodemann HP, Mayer A. Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res. 68(5), 1485-1494 (2008).
76. Shingu T, Fujiwara K, Bogler O et al. Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells. Int. J. Cancer 124(5), 1060-1071 (2009).
77. Carew JS, Nawrocki ST, Kahue CN et al. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood 110(1), 313-322 (2007).
78. Hrzenjak A, Kremser ML, Strohmeier B, Moinfar F, Zatloukal K, Denk H. SAHA induces caspase-independent, autophagic cell death of endometrial stromal sarcoma cells by influencing the mTOR pathway. J. Pathol. 216(4), 495-504 (2008).
79. Yokoyama T, Miyazawa K, Naito M et al. Vitamin K2 induces autophagy and apoptosis simultaneously in leukemia cells. Autophagy 4(5), 629-640 (2008).
80. Wang J, Lian H, Zhao Y, Kauss MA, Spindel S. Vitamin D3 induces autophagy of human myeloid leukemia cells. J. Biol. Chem. 283(37), 25596-25605 (2008).
81. Bellodi C, Lidonnici MR, Hamilton A et al. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J. Clin. Invest. 119(5), 1109-1123 (2009).
82. Ertmer A, Huber V, Gilch S et al. The anticancer drug imatinib induces cellular autophagy. Leukemia 21(5), 936-942 (2007).
83. Yogalingam G, Pendergast AM. Abl kinases regulate autophagy by promoting the trafficking and function of lysosomal components. J. Biol. Chem. 283(51), 35941-35953 (2008).
84. Kamitsuji Y, Kuroda J, Kimura S et al. The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias. Cell Death Differ. 15(11), 1712-1722 (2008).
85. Ding WX, Ni HM, Gao W et al. Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am J. Pathol. 171(2), 513-524 (2007).
86. Zhao J, Brault JJ, Schild A, Goldberg AL. Coordinate activation of autophagy and the proteasome pathway by FoxO transcription factor. Autophagy 4(3), 378-380 (2008).
87. Mammucari C, Milan G, Romanello V et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 6(6), 458-471 (2007).
88. Milani M, Rzymski T, Mellor HR et al. The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. Cancer Res. 69(10), 4415-4423 (2009).
89. Wu WK, Wu YC, Yu L, Li ZJ, Sung JJ, Cho CH. Induction of autophagy by proteasome inhibitor is associated with proliferative arrest in colon cancer cells. Biochem. Biophys. Res. Commun. 374(2), 258-263 (2008).
90. Hoang B, Benavides A, Shi Y, Frost P, Lichtenstein A. Effect of autophagy on multiple myeloma cell viability. Mol. Cancer Ther. (2009).
91. Yazbeck VY, Buglio D, Georgakis GV et al. Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma. Exp. Hematol. 36(4), 443-450 (2008).
92. Griffin JL, Shockcor JP. Metabolic profiles of cancer cells. Nat. Rev. Cancer 4(7), 551-561 (2004).
93. Serkova NJ, Zhang Y, Coatney JL et al. Early detection of graft failure using the blood metabolic profile of a liver recipient. Transplantation 83(4), 517-521 (2007).
94. Tiziani S, Lodi A, Khanim FL, Viant MR, Bunce CM, Gunther UL. Metabolomic profiling of drug responses in acute myeloid leukaemia cell lines. PLoS One 4(1), e4251 (2009).
95. Spratlin JL, Serkova NJ, Eckhardt SG. Clinical applications of metabolomics in oncology: a review. Clin. Cancer Res. 15(2), 431-440 (2009).
96. Spencer B, Potkar R, Trejo M et al. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in a-synuclein models of Parkinson's and Lewy body diseases. J. Neurosci. 29(43), 13578-13588 (2009).
97. Hjelmeland AB, Lattimore KP, Fee BE et al. The combination of novel low molecular weight inhibitors of RAF (LBT613) and target of rapamycin (RAD001) decreases glioma proliferation and invasion. Mol. Cancer Ther. 6(9), 2449-2457 (2007).
98. Chai CY, Huang YC, Hung WC, Kang WY, Chen WT. Arsenic salts induced autophagic cell death and hypermethylation of DAPK promoter in SV-40 immortalized human uroepithelial cells. Toxicol. Lett. 173(1), 48-56 (2007).
99. Hoyer-Hansen M, Bastholm L, Mathiasen IS, Elling F, Jaattela M. Vitamin D analog EB1089 triggers dramatic lysosomal changes and Beclin 1-mediated autophagic cell death. Cell Death Differ. 12(10), 1297-1309 (2005).